SERF1A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.573400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.123400E-01
Normal-vs-Stage2
9.731200E-01
Normal-vs-Stage3
5.520000E-01
Normal-vs-Stage4
2.503200E-01
Stage1-vs-Stage2
3.040000E-01
Stage1-vs-Stage3
2.116600E-01
Stage1-vs-Stage4
8.676400E-01
Stage2-vs-Stage3
2.150000E-01
Stage2-vs-Stage4
4.795000E-01
Stage3-vs-Stage4
3.420200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.099000E-01
Normal-vs-AfricanAmerican
8.242600E-01
Normal-vs-Asian
3.977200E-01
Caucasian-vs-AfricanAmerican
2.076400E-01
Caucasian-vs-Asian
3.541600E-02
AfricanAmerican-vs-Asian
3.127800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.314600E-01
Normal-vs-Female
8.815200E-01
Male-vs-Female
9.980800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.124400E-01
Normal-vs-Age(41-60Yrs)
7.462400E-01
Normal-vs-Age(61-80Yrs)
9.142600E-01
Normal-vs-Age(81-100Yrs)
6.213600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.706000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.370400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.917640E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.977800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.539600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.656200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.721400E-01
Normal-vs-Daily Drinker
6.656400E-01
Normal-vs-Weekly Drinker
6.727000E-01
Normal-vs-Occasional Drinker
2.046400E-01
Normal-vs-Social Drinker
9.879800E-01
Non Drinker-vs-Daily Drinker
2.310600E-01
Non Drinker-vs-Weekly Drinker
7.681400E-01
Non Drinker-vs-Occasional Drinker
1.647030E-01
Non Drinker-vs-Social Drinker
7.592200E-01
Daily Drinker-vs-Weekly Drinker
1.528400E-01
Daily Drinker-vs-Occasional Drinker
3.487000E-01
Daily Drinker-vs-Social Drinker
3.903000E-01
Weekly Drinker-vs-Occasional Drinker
1.324610E-01
Weekly Drinker-vs-Social Drinker
5.000200E-01
Occasional Drinker-vs-Social Drinker
2.028600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.464600E-01
Normal-vs-Grade 2
1.481230E-01
Normal-vs-Grade 3
1.255780E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.510600E-01
Grade 1-vs-Grade 3
7.623700E-02
Grade 1-vs-Grade 4
3.464600E-01
Grade 2-vs-Grade 3
2.637600E-01
Grade 2-vs-Grade 4
1.481230E-01
Grade 3-vs-Grade 4
1.255780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.693200E-01
Normal-vs-NonDiabetic
8.165600E-01
Diabetic-vs-NonDiabetic
4.378000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.588200E-01
Normal-vs-NoPancreatitis
8.400200E-01
Pancreatitis-vs-NoPancreatitis
8.859000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.367200E-01
Normal-vs-N1
9.899800E-01
N0-vs-N1
1.899780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.529400E-01
Normal-vs-TP53-NonMutant
1.922630E-01
TP53-Mutant-vs-TP53-NonMutant
4.429600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
